Cerebras Systems Inc. (CBRS) shares tumbled 11.7% to $96.36 as of November 3, 2026, a sharp decline from the prior close of $109.18. BestStocks flagged the session as a material change for CBRS. Below, we break down what changed for CBRS, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
What happened
CBRS fell 11.7% to $96.36
CBRS tumbled 11.7% in its latest session, moving from $109.18 to $96.36.
ValuationLow confidence
Rel. volume
1.7×
Above Avg
Vs peers
—
No comparable peers
Market cap
$21.8B
NASDAQ Global Market
Analyst target
$301
+211.9% vs price
Price chart
Oct 5 – Nov 2
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details
What it means for Cerebras Systems Inc. investors
For Cerebras Systems Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Positive price momentum; Positive price momentum. Weighing against that: Sharp 11.7% decline — elevated risk; Cerebras fell 6.87% to $163.02, retreating to its IPO price level. Wall Street's consensus price target sits at $300.50, implying +211.9% upside from $96.36. Over the past 90 days analysts logged 1 upgrade and 0 downgrades. BestStocks rates the overall signal quality low (57/100). With earnings roughly 9 days out, the next report is the most likely near-term test of the move.
CBRS price reaction
CBRS last traded at $96.36, down $12.82 (-11.74%) from the previous close of $109.18. The session traded on 1.7× average volume (above avg), so the move carried above-average conviction. Over the past month the stock has ranged between $96.36 and $181.55, and it currently sits about 0% of the way up that band.
Bullish and bearish analyst opinions on Cerebras Systems Inc. (CBRS)
The consensus analyst price target on Cerebras Systems Inc. (CBRS) is $300.50, 211.9% above the recent $96.36. Over the past 90 days analysts logged 1 upgrade, 11 maintains, and 0 downgrades. Here is how the bullish and bearish cases on CBRS line up.
▲ The bullish case
+Wall Street's consensus price target of $300.50 implies +211.9% upside from $96.36.
+The Street's most bullish target is $330.00 (+242.5%).
+1 analyst upgrade in the past 90 days, most recently Freedom Capital Markets to Buy (2026-10-02).
+Positive price momentum.
▼ The bearish case
−Sharp 11.7% decline — elevated risk.
−Cerebras fell 6.87% to $163.02, retreating to its IPO price level.
−Cerebras Systems fell 3.03% to $172.26 after COO Dhiraj Mallick sold 396,000 shares and CFO initiated an exit under a trading plan, per filings reported by DefenseWorld and 247wallst.
Bull vs bear balanceBearish Shift
BearishNeutralBullish
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Nov 2, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Cerebras Systems (CBRS) fell 7.26% to $106.80 following a critical short-seller report from Culper Research alleging that the company's wafer-scale AI processors could degrade or fail within 1.5 to 2.5 years, combined with broader semiconductor sector weakness after Intel issued weaker-than-expected Q4 guidance (per web catalyst synthesis and Yahoo Finance). The decline has also triggered shareholder class-action investigations from multiple firms including Block & Leviton (newsfilecorp.com, morningstar.com). Volume of 5.18M shares reflects normal intraday pace at 0.73x historical average for this time of session.
Cerebras Systems (CBRS) fell 6.25% to $110.61 in early trading, declining from a $117.98 previous close. No specific intraday catalyst has emerged; the move occurs ahead of the company's earnings report scheduled for November 12, 2026, where consensus expects a loss of $0.15 per share. Volume data remains unreliable at this early stage of the session.
Cerebras Systems shares fell 9.02% to $129.34 in intraday trading with volume at 1.16x the historical average for this time of session. No specific catalyst driver was identified in available reporting; the decline occurred against a backdrop of earlier positive analyst sentiment (per Investing.com articles from June and May 2026 documenting analyst initiations and prior pullbacks). The move represents a reversal from recent strength.
Cerebras stock fell 10.36% to $147.17, driven by OpenAI partnership concerns and share lockup pressures. According to Barron's, industry reports (SemiAnalysis) suggest OpenAI's GPT-6.1 Sol is using Nvidia GPUs rather than Cerebras hardware, undermining confidence in the key commercial relationship despite reassurances from CEO Sam Altman. Volume surged to 10.4M shares—2.96x the historical average at this point in the session—as approaching lockup expirations flood the market with newly eligible supply.
Cerebras fell 6.87% to $163.02, retreating to its IPO price level. The decline follows commentary highlighting the company's dependence on a narrow customer base—roughly 80–85% of near-term revenue consensus through October 2026 concentrated with OpenAI—amid an otherwise bullish narrative about its inference cloud and differentiated chip architecture (Seeking Alpha). Volume of 5.5M shares ran 1.20x normal for this point in the session.
OpenAI CEO Sam Altman publicly called Cerebras Systems a "close partner," easing investor concerns about hardware competition from Nvidia chips powering OpenAI's newest ultrafast tiers (Yahoo Finance). CBRS rose 7.79% to $179.40, reversing prior losses driven by competition and insider lockup expiration fears.
Cerebras Systems fell 3.03% to $172.26 after COO Dhiraj Mallick sold 396,000 shares and CFO initiated an exit under a trading plan, per filings reported by DefenseWorld and 247wallst. The stock has slipped below its IPO price amid the insider selling activity.
Cerebras Systems fell 7.10% to $181.11 intraday, continuing a broader three-month decline of 19% driven by operating losses, margin pressure, and customer concentration concerns (Zacks, Sep 17, 2026). The stock has faced repeated pullbacks in recent weeks, including a 6.5% slide in August after a prior 15% surge, suggesting renewed skepticism about profitability and revenue durability.
In-depth CBRS event analyses
Permanent, dated analyses of CBRS's most significant sessions.
CBRS tumbled 11.7% to $96.36. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did CBRS stock fall?
CBRS lost 11.74% ($12.82) versus the prior close of $109.18, last trading at $96.36 on 1.7× average volume.
When is Cerebras Systems Inc.'s next earnings date?
CBRS's next earnings report is estimated for 2026-11-12 — about 9 days away.
What is the analyst price target for CBRS?
The consensus analyst price target for CBRS is $300.50, about 211.9% above the current $96.36. Over the past 90 days, analysts recorded 1 upgrade, 11 maintains, and 0 downgrades.
How BestStocks tracks CBRS
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared CBRS-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for CBRS, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 3, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
